Humacyte, Inc. (HUMA)
1.045
-0.30
(-22.01%)
USD |
NASDAQ |
Jun 11, 14:20
Humacyte Market Cap : 232.01M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 297.51M |
| June 09, 2026 | 308.61M |
| June 08, 2026 | 306.39M |
| June 05, 2026 | 299.73M |
| June 04, 2026 | 330.81M |
| June 03, 2026 | 310.83M |
| June 02, 2026 | 308.61M |
| June 01, 2026 | 321.93M |
| May 29, 2026 | 288.62M |
| May 28, 2026 | 284.18M |
| May 27, 2026 | 255.32M |
| May 26, 2026 | 246.44M |
| May 22, 2026 | 233.12M |
| May 21, 2026 | 226.46M |
| May 20, 2026 | 203.64M |
| May 19, 2026 | 183.23M |
| May 18, 2026 | 199.46M |
| May 15, 2026 | 206.50M |
| May 14, 2026 | 222.02M |
| May 13, 2026 | 250.88M |
| May 12, 2026 | 202.04M |
| May 11, 2026 | 222.02M |
| May 08, 2026 | 235.34M |
| May 07, 2026 | 239.78M |
| May 06, 2026 | 218.31M |
| Date | Value |
|---|---|
| May 05, 2026 | 200.24M |
| May 04, 2026 | 205.32M |
| May 01, 2026 | 189.89M |
| April 30, 2026 | 186.90M |
| April 29, 2026 | 182.06M |
| April 28, 2026 | 188.16M |
| April 27, 2026 | 178.93M |
| April 24, 2026 | 155.41M |
| April 23, 2026 | 157.21M |
| April 22, 2026 | 156.50M |
| April 21, 2026 | 146.31M |
| April 20, 2026 | 152.64M |
| April 17, 2026 | 157.68M |
| April 16, 2026 | 151.77M |
| April 15, 2026 | 163.43M |
| April 14, 2026 | 153.44M |
| April 13, 2026 | 148.78M |
| April 10, 2026 | 143.29M |
| April 09, 2026 | 134.77M |
| April 08, 2026 | 144.65M |
| April 07, 2026 | 134.74M |
| April 06, 2026 | 144.31M |
| April 02, 2026 | 142.63M |
| April 01, 2026 | 131.41M |
| March 31, 2026 | 134.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 341.18M |
| Protalix Biotherapeutics, Inc. | 165.57M |
| Agenus, Inc. | 130.01M |
| Amgen, Inc. | 192.02B |
| BioCryst Pharmaceuticals, Inc. | 2.182B |
Market Cap Related Metrics
| PS Ratio | 90.50 |
| Price to Book Value | 19.96 |
| Price | 1.045 |
| Earnings Yield | -55.00% |